36C24023K1012↗

Name: 36C24023K1012: Express Report: Pharmaceutical Prime Vendor (Ppv)fy2023 September
Creator: SpendQuery

EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2023 SEPTEMBER

Delivery Order · Department of Veterans Affairs · to Mckesson Corporation (UEI S1RUKWWRYFL6) · data as of 2026-09-30

Obligated to date$901.98M1 action

Current value$901.98Mwith options exercised

Period2023-09-01 → 2023-09-30current end date

What it is

Product or service: Drugs and Biologicals (PSC 6505)
Industry: Pharmaceutical Preparation Manufacturing (NAICS 325412)
Contracting office: Vha Chief Logistics Office (36C240) (36C240)
Competition: Full and open competition
Pricing: Firm fixed price
How it was bought: Single-award IDIQ · under 36W79720D0001
Where the work is: Dallas, TX · district TX-33

Obligations by fiscal year

FY2023$901.98M

SpendQuery holds FY2023 on; earlier years are on USAspending.gov.

Subcontractors: where the money went next

No subawards reported for this award. Primes report subawards of $30,000 or more; many awards have none.

Every action

1 action since 2023-09-01. Each is a modification or amendment with the money it added or took back.

Date	Modification	Kind	Amount	What the agency wrote
2023-09-01	0		$901.98M	EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2023 SEPTEMBER

Source: USAspending.gov prime award transactions and FSRS subaward reports, as loaded by SpendQuery (data as of 2026-09-30). Amounts are obligations (money committed), not outlays. The official record on USAspending.gov ↗